Skip to content

Palliative performance scale as a prognostic tool among Egyptian Parkinson's disease patients

Palliative performance scale as a prognostic tool among Egyptian Parkinson's disease patients: a hospital based pilot study - Palliative performance scale among Egyptian Parkinson's disease patients

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000036595
Enrollment
30
Registered
2019-04-25
Start date
2019-05-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Palliative performance scale

Interventions

None listed

Sponsors

Kasralainy hospital, Faculty of medicine, Cairo University; Egypt
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Egyptian patients diagnosed with IPD according to UK Parkinson's Disease Society Brain Bank Clinical Diagnostic criteria

Exclusion criteria

Exclusion criteria: Vascular PD (VP) Parkinson plus syndrome (PPS) patients cognitive impaired patients (MMSE=24 or abnormal for education level) patients with negative levodopa challenge test wheelchair bound or bed ridden patients, and severely disabled patients with Hoehn and Yahr scale (H & Y) stage 4 or 5

Design outcomes

Primary

MeasureTime frame
change in clinical motor scales including H & Y scale and/or UPDRS (Part III and/or Total score) over time (6-month duration)

Secondary

MeasureTime frame
change in PPS score over time

Countries

Africa

Contacts

Public ContactWael Wael Ibrahim

Kasralainy hospital, Faculty of Medicine, Cairo University Neurology

dr.wael_ezzat@yahoo.com+201111919927

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026